ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 and its subsidiaries (collectively “Aspen” or “the Group”) MANUFACTURING DAY & ASPEN NOTRE-DAME-De-BONDEVILLE SITE VISIT – 29TH NOVEMBER 2023 Shareholders are advised that Aspen will be hosting a Manufacturing Day and site visit at its French facility for shareholders, investor representatives and analysts on Wednesday, 29th November 2023 at 09h00 CAT (GMT +2). Stakeholders interested in attending the site visit in-person are requested to contact Aspen Investor Relations by emailing investorrelations@aspenpharma.com. Due to limited capacity on site, Aspen reserves the right to manage the RSVP for in-person attendees. Agenda: 08h00-08h30 Registration 09h00-10:30 Presentations (session 1) 10:30- 13:30 Site tour of the NDB facilities (session 2) 14:30-17:00 Presentations (session 3) Sessions 1 and 3 will be available via webcast and can be accessed via the webcast link: https://edge.media- server.com/mmc/p/s7m5v29z/. A playback of the webcast will also be made available on Aspen’s website, https://www.aspenpharma.com, approximately 2 hours after the conclusion of the live presentation. A copy of the presentation will be available on the Company's website, https://www.aspenpharma.com. For any further details with regards to this, please contact Aspen Investor Relations by emailing investorrelations@aspenpharma.com. Durban 27 October 2023 Sponsor Investec Bank Limited